Executive Branch

HHS Cancels $500 Million in mRNA Vaccine Development Contracts

The mRNA development activities, managed under the Biomedical Advanced Research and Development Authority, are worth nearly $500 million.
HHS Cancels $500 Million in mRNA Vaccine Development Contracts
Health and Human Services Secretary Robert F. Kennedy Jr. testifies during a House Energy and Commerce Committee in Washington, on June 24, 2025. AP Photo/Mariam Zuhaib
Jeff Louderback
|Updated:
0:00

Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that 22 mRNA vaccine development contracts are being canceled and redirected “because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.”

The mRNA development activities are spearheaded by the Biomedical Advanced Research and Development Authority (BARDA), which is managed by Global Health Investment Corporation.

Jeff Louderback
Jeff Louderback
Reporter
Jeff Louderback covers major news and politics, including the Make America Healthy Again movement and regenerative farming. Since joining The Epoch Times in 2022, he has covered national elections, the Robert F. Kennedy Jr. presidential campaign, the East Palestine train derailment, and the aftermath of Hurricane Helene in western North Carolina. Jeff has 30-plus years of professional experience as a reporter, editor, and author.